KNOPP BIOSCIENCES LLC

Profile

Company Names

KNOPP BIOSCIENCES LLC

Addresses

2100 WHARTON STREET, SUITE 615, SUITE 615, PITTSBURGH, PA 15203

2100 WHARTON STREET, SUITE 615, PITTSBURGH, PA 15203

2100 WHARTON STREET, SUITE 615, PITTSBURGH, PA 15203

Phone Numbers

412-488-1776

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$209,271,109.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2020-12-21 
$1.00 
$1.00 
$0.00 
Equity 
6
2020-06-30 
$12,608,668.00 
$26,018,321.00 
$13,409,653.00 
Equity 
5
2020-03-02 
$1,000,000.00 
$3,000,000.00 
$2,000,000.00 
Debt 
4
2019-02-14 
$12,719,711.00 
$26,000,000.00 
$13,280,289.00 
Equity 
3
2014-05-23 
$28,000,000.00 
$31,329,499.00 
$3,329,499.00 
Debt 
2
2012-07-19 
$14,942,729.00 
$30,000,000.00 
$15,057,271.00 
Equity 
1
2010-08-23 
$140,000,000.00 
$140,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
C. 
DAVID 
ADAIR 
DIRECTOR
MICHAEL 
E. 
BOZIK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
STEPHEN 
BUTTS 
DIRECTOR
STEVE 
 
DWORETZKY 
EXECUTIVE OFFICER
STEVEN 
 
DWORETZKY 
EXECUTIVE OFFICER
BENJAMIN 
A. 
GOMEZ 
DIRECTOR
VALENTIN 
K. 
GRIBKOFF 
EXECUTIVE OFFICER
GREGORY 
T. 
HEBRANK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
EVAN 
W. 
INGERSOLL 
EXECUTIVE OFFICER
SURESH 
 
KHEMANI 
EXECUTIVE OFFICER
SHANE 
 
KOVACS 
DIRECTOR
MARK 
 
KRESTON 
EXECUTIVE OFFICER
FRANK 
J. 
LUCCHINO, JR. 
EXECUTIVE OFFICER
JAMES 
 
MATHER 
EXECUTIVE OFFICER
THOMAS 
V. 
PETZINGER JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
THOMAS 
 
PETZINGER, JR. 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
THOMAS 
V. 
PETZINGER, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CALMAN 
 
PRUSSIN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-03-02 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SATURN CAPITAL, INC.
NONE
NONE
MIP GLOBAL, INC.
NONE
NONE
STILLPOINT CAPITAL, LLC
NONE
NONE
PICKWICK CAPITAL PARTNERS, LLC